VideoPod

About this episode

Shigellosis is an infection of the Shigella bacteria with over 164 million cases each year leading to 1.1 million deaths. The ever-increasing antibiotic resistance of the bacteria means we need alternatives or supplements to existing antibiotics. Dr Kristin Parent from Michigan State University is working on exciting, collaborative projects hunting for bacteriophages to be used in novel therapeutics.

Original Article Reference

This video is a summary of https://doi.org/10.33548/SCIENTIA778

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Increase the impact of your research!

More episodes

Dr. Philippe Vangrieken | New Insights into Preeclampsia: Advancing from Vascular Health Challenges to Early Diagnosis

Preeclampsia is a serious condition that affects up to 8% of pregnancies, leading to high blood pressure and organ...

Dr. Chandrika Varadachari | Caged Urea: A Smart Fertilizer That Boosts Crop Yields and Protects the Environment

In an era of increasing urgency to address environmental degradation, the impact of conventional agricultural...

Redefining Cannabis Potency with CannaMetrix

Cannabis products have surged in popularity, for both medicinal and recreational use. Despite the wide range of...

Balancing Ethics and Innovation in Biobanking

Biobanking, which describes the collection, storage and sharing of human biological samples and data, has become...

Dr. Ramesh Jha | Creating and Testing Genetic Mutations Efficiently

From the genes contained in our DNA, the proteins within our bodies are born. As researchers progress in their ability...

Professor Peter Palese | New COVID-19 Vaccines Aim to Increase Global Access and Protect Against Emerging Variants

As COVID-19 continues to evolve, there is an urgent need for vaccines that are cheaper, easier to produce, and more...